TNDM earnings call for the period ending March 31, 2021.
News & Analysis: Tandem Diabetes Care
Both of these companies have a long runway for growth.
TNDM earnings call for the period ending December 31, 2020.
Up 50% in 2020 with significant upside still ahead, Tandem Diabetes Care has a long runway for growth.
TNDM earnings call for the period ending September 30, 2020.
This diabetes-focused healthcare company and financial services giant are ready to reward their shareholders.
These three stocks are among the few winners to emerge from the coronavirus stock market.
DexCom, Tandem Diabetes, and Novo Nordisk have plenty of momentum and growth ahead, making them excellent buys this month.
TNDM earnings call for the period ending June 30, 2020.
Which of these two diabetes partners is more likely to be the bigger winner over the long run?